Cargando…
Metabolomics studies on cachexia in patients with cancer: a scoping review protocol
INTRODUCTION: Cancer seriously threatens human health worldwide. Cancer cachexia is one of the life-threatening consequences that occurs commonly in patients with cancer, and severely worsens patient survival, prognosis and quality of life. Previous studies have demonstrated that cancer cachexia is...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006824/ https://www.ncbi.nlm.nih.gov/pubmed/35414542 http://dx.doi.org/10.1136/bmjopen-2021-052125 |
_version_ | 1784686742027108352 |
---|---|
author | Fu, Liang Chen, Lin Li, Rufang Xu, Wenxia Fu, Jianfei Ye, Xianghong |
author_facet | Fu, Liang Chen, Lin Li, Rufang Xu, Wenxia Fu, Jianfei Ye, Xianghong |
author_sort | Fu, Liang |
collection | PubMed |
description | INTRODUCTION: Cancer seriously threatens human health worldwide. Cancer cachexia is one of the life-threatening consequences that occurs commonly in patients with cancer, and severely worsens patient survival, prognosis and quality of life. Previous studies have demonstrated that cancer cachexia is closely related to differential metabolites and metabolic pathways based on metabolomics analysis. This scoping review protocol, therefore, aims to provide the strategy for a formal scoping review that will summarise the differential metabolites and related metabolic pathways of cachexia in patients with cancer. METHODS AND ANALYSIS: The proposed scoping review will follow the Arksey and O’Malley’s methodological framework, Levac et al’s recommendations for applying this framework, and Peters’ enhancements of the framework. The key information from the selected studies will be extracted, including author, year of publication, cachexia definition, country/origin, study design, setting, population and sample size, biological specimens, independent variables, independent variables’ measure and statistical analysis. A summary of metabolites will be divided into several sections depending on the biological specimen. Differential metabolites will be compared between paired groups, and the number and names of related metabolic pathways will be counted and described. The reporting of this scoping review will be in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. This is a scoping review protocol and describes the planned review process and provides data examples extracted from a pilot study to confirm the feasibility of further investigation of the subject. ETHICS AND DISSEMINATION: An ethical approval is not required for this scoping review protocol, nor for the scoping review. The results of this scoping review will be disseminated through publication in a peer-reviewed journal, or presentation at a national or international conference. |
format | Online Article Text |
id | pubmed-9006824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-90068242022-05-02 Metabolomics studies on cachexia in patients with cancer: a scoping review protocol Fu, Liang Chen, Lin Li, Rufang Xu, Wenxia Fu, Jianfei Ye, Xianghong BMJ Open Oncology INTRODUCTION: Cancer seriously threatens human health worldwide. Cancer cachexia is one of the life-threatening consequences that occurs commonly in patients with cancer, and severely worsens patient survival, prognosis and quality of life. Previous studies have demonstrated that cancer cachexia is closely related to differential metabolites and metabolic pathways based on metabolomics analysis. This scoping review protocol, therefore, aims to provide the strategy for a formal scoping review that will summarise the differential metabolites and related metabolic pathways of cachexia in patients with cancer. METHODS AND ANALYSIS: The proposed scoping review will follow the Arksey and O’Malley’s methodological framework, Levac et al’s recommendations for applying this framework, and Peters’ enhancements of the framework. The key information from the selected studies will be extracted, including author, year of publication, cachexia definition, country/origin, study design, setting, population and sample size, biological specimens, independent variables, independent variables’ measure and statistical analysis. A summary of metabolites will be divided into several sections depending on the biological specimen. Differential metabolites will be compared between paired groups, and the number and names of related metabolic pathways will be counted and described. The reporting of this scoping review will be in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. This is a scoping review protocol and describes the planned review process and provides data examples extracted from a pilot study to confirm the feasibility of further investigation of the subject. ETHICS AND DISSEMINATION: An ethical approval is not required for this scoping review protocol, nor for the scoping review. The results of this scoping review will be disseminated through publication in a peer-reviewed journal, or presentation at a national or international conference. BMJ Publishing Group 2022-04-11 /pmc/articles/PMC9006824/ /pubmed/35414542 http://dx.doi.org/10.1136/bmjopen-2021-052125 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Oncology Fu, Liang Chen, Lin Li, Rufang Xu, Wenxia Fu, Jianfei Ye, Xianghong Metabolomics studies on cachexia in patients with cancer: a scoping review protocol |
title | Metabolomics studies on cachexia in patients with cancer: a scoping review protocol |
title_full | Metabolomics studies on cachexia in patients with cancer: a scoping review protocol |
title_fullStr | Metabolomics studies on cachexia in patients with cancer: a scoping review protocol |
title_full_unstemmed | Metabolomics studies on cachexia in patients with cancer: a scoping review protocol |
title_short | Metabolomics studies on cachexia in patients with cancer: a scoping review protocol |
title_sort | metabolomics studies on cachexia in patients with cancer: a scoping review protocol |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006824/ https://www.ncbi.nlm.nih.gov/pubmed/35414542 http://dx.doi.org/10.1136/bmjopen-2021-052125 |
work_keys_str_mv | AT fuliang metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol AT chenlin metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol AT lirufang metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol AT xuwenxia metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol AT fujianfei metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol AT yexianghong metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol |